ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 756619 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 756619; 2) Community: the network communities that were significantly associated with the response to NSC 756619; 3) Molecule: the relationships between components within communities and NSC 756619; 4) MDR: the compounds that were significantly associated with the NSC 756619.

NSC Compound Enrichment Correlation
NSC 224131 N-Phosphonacetyl-L-aspartate 0.0222343516878695 -0.097383223
NSC 294712 Lobolide 0.0222343516878695 -0.2506148
NSC 340847 4-Selenazolecarboxamide, 2-.beta.-D-ribofuranosyl- 0.0222343516878695 -0.36353517
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0222343516878695 -0.094545814
NSC 41566 Ethyl phenylpropiolate 0.0222343516878695 -0.10182778
NSC 46401 .alpha.-Sarcin 0.0222343516878695 0.22276755
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.0222343516878695 -0.21218663
NSC 609699 Topotecan hydrochloride 0.0222343516878695 0.040464977
NSC 610459 Camptothecin Derivative 0.0222343516878695 0.026885226
NSC 620277 4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline 0.0222343516878695 -0.52779907
Total:106  Current:57    [First] [Prev] [Next] [Last]